[18F]LUZ5-d8

N/A

Report date: 2025/12/02 10:07:15

NME

Base Information

Drug Name[18F]LUZ5-d8

Drug Alias Name[18F]LUZ5-d8

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Fluorine > 18FRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionPositron-emission tomography enhancersCannabinoid CB2 receptor modulators

TargetsCannabinoid CB2 receptor

Therapy Area/IndicationsMetabolic Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesLeipzig University

China Registration ClassN/A

Develop Information

Active CompaniesLeipzig University

Inactive CompaniesN/A

Active IndicationsMetabolic Diseases

Inactive IndicationsN/A

Other Information

ATC CodeN/A